Search results
Should You Buy Arm Holdings Right Now or Wait for a Pullback?
Motley Fool via Yahoo Finance· 6 days agoDeciding when to purchase a stock is perhaps an investor's most challenging decision. This is...
Google-backed Tempus AI pops by as much as 15% in Nasdaq stock market debut
NBC Philadelphia· 16 hours agoTempus AI rose by as much as 15% in its market debut Friday on the Nasdaq after going public under the ticker symbol "TEM." Before going public ...
Here’s Why Wasatch Micro Cap Value Strategy Get Back into GCM Grosvenor (GCMG) Stock
Insider Monkey via Yahoo Finance· 5 days agoWasatch Global Investors, an asset management company, released its “Wasatch Micro Cap Value...
Should You Buy Arm Holdings Right Now or Wait for a Pullback?
The Motley Fool via AOL· 6 days agoDeciding when to purchase a stock is perhaps an investor's most challenging decision. This is...
Down 27% From Its 52-Week High, Is Now the Time to Buy Fortinet Stock?
The Motley Fool via AOL· 6 days agoFor investors who are confident in the company's long-term potential, the recent stock price...
Trinity Capital Inc. Declares Cash Dividend of $0.51 per Share for the Second Quarter of 2024
Morningstar· 1 day agoTrinity Capital Inc. (Nasdaq: TRIN) ("Trinity Capital" or the "Company"), a leading provider of diversified financial solutions to growth stage companies, today announced ...
Where Will Zscaler Stock Be in 1 Year?
Motley Fool via Yahoo Finance· 6 days agoZscaler is still growing as it gains more enterprise and government contracts, but it has two glaring weaknesses. First, it's stayed unprofitable on a...
Esports Company Cofounded By Son Of Casino Magnate Stanley Ho Files For U.S. IPO
Forbes· 1 day agoMario Ho’s NIP Group is backed by the likes of the Wuhan government, SIG and ZhenFund, among others.
CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
Digital Journal· 12 hours agoAny forward-looking statements contained in this press release speak only as of its date. CNS undertakes no obligation to update any forward-looking statements contained in this press release ...
This Needham biotech's stock has gone up 700% in 3 months - Boston Business Journal
The Business Journals· 5 days agoCandel Therapeutics Inc. has been working on its comeback story. After its initial public offering...
